![](/img/cover-not-exists.png)
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy
Spiegel, Jay Y., McNamara, Caroline, Kennedy, James A., Panzarella, Tony, Arruda, Andrea, Stockley, Tracy, Sukhai, Mahadeo, Thomas, Mariam, Bartoszko, Justyna, Ho, Jenny, Siddiq, Nancy, Maze, Dawn, ScVolume:
1
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2017009530
Date:
September, 2017
File:
PDF, 1.40 MB
2017